Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer
{{output}}
Prostate-specific antigen (PSA) is used to screen for prostate cancer for decades. However, PSA has poor specificity in prostate cancer screening within the 4.0- to 10.0-ng/mL range. This study aimed to develop a new prediction model for PCa in patients with a... ...
